AU2001292842A1 - Compositions and methods relating to prostate specific genes and proteins - Google Patents

Compositions and methods relating to prostate specific genes and proteins

Info

Publication number
AU2001292842A1
AU2001292842A1 AU2001292842A AU9284201A AU2001292842A1 AU 2001292842 A1 AU2001292842 A1 AU 2001292842A1 AU 2001292842 A AU2001292842 A AU 2001292842A AU 9284201 A AU9284201 A AU 9284201A AU 2001292842 A1 AU2001292842 A1 AU 2001292842A1
Authority
AU
Australia
Prior art keywords
proteins
compositions
specific genes
prostate specific
methods relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292842A
Other languages
English (en)
Inventor
Shujath Ali
Robert Cafferkey
Herve Recipon
Yongming Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Publication of AU2001292842A1 publication Critical patent/AU2001292842A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001292842A 2000-09-19 2001-09-19 Compositions and methods relating to prostate specific genes and proteins Abandoned AU2001292842A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23374600P 2000-09-19 2000-09-19
US60233746 2000-09-19
PCT/US2001/029386 WO2002024718A1 (fr) 2000-09-19 2001-09-19 Compositions et methodes concernant des genes et des proteines specifiques de la prostate

Publications (1)

Publication Number Publication Date
AU2001292842A1 true AU2001292842A1 (en) 2002-04-02

Family

ID=22878529

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292842A Abandoned AU2001292842A1 (en) 2000-09-19 2001-09-19 Compositions and methods relating to prostate specific genes and proteins

Country Status (3)

Country Link
US (2) US20030031678A1 (fr)
AU (1) AU2001292842A1 (fr)
WO (1) WO2002024718A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7019498A (en) 1997-04-10 1998-10-30 Diagnocure Inc. Pca3, pca3 genes, and methods of use
CA2385477C (fr) 1999-09-29 2009-11-03 Diagnocure Inc. Variantes l'arnm du pca3 dans les tissus benins et malins de la prostate
AU2002246708A1 (en) 2000-12-15 2002-08-12 Agensys, Inc. Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer
US6897024B2 (en) 2001-05-31 2005-05-24 Stichting Katholieke Universiteit More Particularly The University Medical Centre Nijmegen Nucleic acid molecules comprising the promoter for PCA3, and uses thereof
DE10230692A1 (de) * 2002-07-08 2004-02-12 Epigenomics Ag Verfahren und Nukleinsäuren für die Analyse von Methylierungsmustern innerhalb des DD3-Gens
CA2513780C (fr) 2003-02-07 2014-12-30 Diagnocure Inc. Procede de detection de cancer de la prostate dans un echantillon
WO2004092213A1 (fr) * 2003-04-08 2004-10-28 The Government Of The United States Of America As Represented By The Secretary, Department Of Healthand Human Services Gene exprime dans le cancer de la prostate, procedes et utilisation correspondants
KR20060029214A (ko) * 2003-05-05 2006-04-05 다우 아그로사이언시즈 엘엘씨 이식 유전자 식물 세포들로부터 유래된 안정한 면역예방적및 치료적 조성물들 및 생산방법
EP2471923B1 (fr) 2004-05-28 2014-08-20 Asuragen, Inc. Procédés et compositions impliquant du microARN
EP2302051B1 (fr) 2004-11-12 2015-01-07 Asuragen, Inc. Procédés et compositions impliquant l'ARNmi et des molécules inhibitrices de l'ARNmi
CA2491067A1 (fr) 2004-12-24 2006-06-24 Stichting Katholieke Universiteit Rapport entre arnm dans les sediments urinaires ou l'urine en tant que marqueur pronostique du cancer de la prostate
CA2663962A1 (fr) * 2006-09-19 2008-03-27 Asuragen, Inc. Genes regules mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p et voies de signalisation utiles comme cibles dans une intervention therapeutique
CA2664383C (fr) * 2006-09-19 2017-08-22 Asuragen, Inc. Micro arn exprimes par differenciation dans les maladies du pancreas, et leur utilisation
CN101622348A (zh) * 2006-12-08 2010-01-06 奥斯瑞根公司 作为治疗性干预靶标的miR-20调节的基因和途径
AU2007333109A1 (en) * 2006-12-08 2008-06-19 Asuragen, Inc. Functions and targets of let-7 micro RNAs
EP2104735A2 (fr) * 2006-12-08 2009-09-30 Asuragen, INC. Gènes et voies génétiques régulés par mir-21 utilisés en tant que cibles pour une intervention thérapeutique
US20090175827A1 (en) * 2006-12-29 2009-07-09 Byrom Mike W miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
US20090131354A1 (en) * 2007-05-22 2009-05-21 Bader Andreas G miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
US20090232893A1 (en) * 2007-05-22 2009-09-17 Bader Andreas G miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
WO2008154333A2 (fr) * 2007-06-08 2008-12-18 Asuragen, Inc. Gènes et chemins régulés par mir-34 en tant que cibles pour une intervention thérapeutique
EP2198050A1 (fr) 2007-09-14 2010-06-23 Asuragen, INC. Microarn exprimés de manière différentielle dans le cancer du col de l'utérus et leurs utilisations
US20090186015A1 (en) * 2007-10-18 2009-07-23 Latham Gary J Micrornas differentially expressed in lung diseases and uses thereof
US8071562B2 (en) * 2007-12-01 2011-12-06 Mirna Therapeutics, Inc. MiR-124 regulated genes and pathways as targets for therapeutic intervention
WO2009086156A2 (fr) * 2007-12-21 2009-07-09 Asuragen, Inc. Gènes et voies régulés par mir-10 servant de cibles dans le cadre d'une intervention thérapeutique
US20090263803A1 (en) * 2008-02-08 2009-10-22 Sylvie Beaudenon Mirnas differentially expressed in lymph nodes from cancer patients
EP2268832A2 (fr) * 2008-03-06 2011-01-05 Asuragen, INC. Marqueurs microrna pour la récurrence d un cancer colorectal
EP2271757A2 (fr) * 2008-03-26 2011-01-12 Asuragen, INC. Compositions et procédés liés à mir-16 et à la thérapie contre le cancer de la prostate
US8258111B2 (en) 2008-05-08 2012-09-04 The Johns Hopkins University Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
US20100179213A1 (en) * 2008-11-11 2010-07-15 Mirna Therapeutics, Inc. Methods and Compositions Involving miRNAs In Cancer Stem Cells
WO2013040251A2 (fr) 2011-09-13 2013-03-21 Asurgen, Inc. Méthodes et compositions incluant mir-135b, permettant de faire la distinction entre un cancer du pancréas et une maladie pancréatique bénigne
EP3333186B9 (fr) 2012-03-28 2023-10-04 Gadeta B.V. Échange de chaîne de récepteurs de lymphocytes t gamma 9 delta 2 combinatoires
CA3026180A1 (fr) 2016-06-10 2017-12-14 Gadeta B.V. Recepteurs de lymphocytes t gamma delta restreints a l'antigene leucocytaire humain et leurs methodes d'utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US73623A (en) * 1868-01-21 Improvement in hakvester-eakes
US5985638A (en) * 1997-03-26 1999-11-16 Incyte Pharmaceuticals, Inc. Microsomal signal peptidase subunit
GB9907860D0 (en) * 1999-04-07 1999-06-02 Smithkline Beecham Biolog Novel compounds
CA2403508A1 (fr) * 2000-04-18 2001-10-25 Human Genome Sciences, Inc. Polynucleotides, polypeptides et anticorps matriciels extracellulaires

Also Published As

Publication number Publication date
US20030031678A1 (en) 2003-02-13
WO2002024718A1 (fr) 2002-03-28
US20060019322A1 (en) 2006-01-26

Similar Documents

Publication Publication Date Title
AU2001292842A1 (en) Compositions and methods relating to prostate specific genes and proteins
AU2002249787A1 (en) Compositions and methods relating to lung specific genes and proteins
AU2002245031A1 (en) Compositions and methods relating to prostate specific genes and proteins
AU2002219988A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2002243972A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2001286810A1 (en) Compositions and methods relating to lung specific genes
AU2001297741A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2002220009A1 (en) Compositions and methods relating to lung specific genes and proteins
AU2002217991A1 (en) Compositions and methods relating to prostate specific genes and proteins
AU2002239409A1 (en) Compositions and methods relating to colon specific genes and proteins
AU2002236579A1 (en) Compositions and methods relating to prostate specific genes and proteins
AU2002241557A1 (en) Compositions and methods relating to prostate specific genes and proteins
AU2002364968A1 (en) Compositions and methods relating to hepatic specific genes and proteins
AU2002239413A1 (en) Compositions and methods relating to prostate specific genes and proteins
AU2002239412A1 (en) Compositions and methods relating to prostate specific genes and proteins
AU2001297804A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2002357382A1 (en) Compositions and methods relating to endometrial specific genes and proteins
AU2002335686A1 (en) Compositions and methods relating to prostate specific genes and proteins
AU2002235164A1 (en) Compositions and methods relating to prostate specific genes and proteins
WO2002036808A8 (fr) Compositions et methodes relatives a des genes et des proteines specifiques de la prostate
AU2001277937A1 (en) Compositions and methods relating to lung specific genes
AU2002236534A1 (en) Compositions and methods relating to ovary specific genes and proteins
AU2002241730A1 (en) Compositions and methods relating to lung specific genes and proteins
AU2002253946A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2002243444A1 (en) Compositions and methods relating to colon specific genes and proteins